Emerging role of adenosine in brain disorders and amyotrophic lateral sclerosis

Credit: Mary Ann Liebert, Inc publishers New Rochelle, NY, December 6, 2019 -The role of adenosine in neurodegeneration and neuroregeneration has led to growing attention on adenosine...

Authors take in-depth look at risks associated with medical AI/ML systems

Artificial intelligence and machine learning (AI/ML) are increasingly transforming the healthcare sector. From spotting malignant tumours to reading CT scans and mammograms, AI/ML-based technology is faster and more accurate than traditional devices - or...

$70M from Sidney and Caroline Kimmel to Fund Thomas Jefferson U. Cancer Research Building

Caroline and Sidney Kimmel Philanthropists Sidney and Caroline Kimmel have gifted $70 million to Thomas Jefferson University toward construction of a new research building that is intended to enhance “big ideas” research at its Sidney...

The growth of biotechnology and service Outsourcing network – Industry Global News 24

Healthcare4 Min read The growth of biotechnology and service Outsourcing network Published On 06 Dec 2019 02:40 PM SHARE THIS ARTICLE   In Australia, can be clearly noticed that the growth of biotechnology...

Update: Cancer Immunotherapy Biotech Files for Insolvency

Update (06/12/2019): Following the phase III failure of its immunotherapy drug for colorectal cancer in the summer, the German company Mologen has filed for insolvency. Published 06/08/2019 A DNA immunotherapy drug developed by the German company...

Polyplus-transfection expands GMP portfolio to provide additional flexibility for gene and cell therapy developers

Dec 6 2019 Polyplus-transfection(R) SA, the leading biotechnology company that supports gene and cell therapy by supplying innovative transfection solutions, today announces the availability of the first GMP-grade transfection reagent PEIpro(R)-GMP in additional conditioning that...

First investigational drug therapy for liver disease NASH awaiting FDA approval

Global clinical trial designed in collaboration with VCU successfully tested a drug therapy to treat NASH, a chronic liver disease and the fastest-growing reason for liver transplantation in the U.S. Credit: Virginia Commonwealth University

German Biotech Raises €7M Series A to Treat Acute Heart Failure

4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of a first-in-class antibody drug that could reduce mortality in acute heart failure. The round was led by Brandenburg Kapital, a...

Smart, self-powered patch to put an end to €2.3 trillion bill caused by rust...

The cost of corrosion runs to 3-4% of the gross world product annually, and therefore there is increasing focus on monitoring infrastructure; Danish researchers are developing a smart patch that can cut huge amounts...

Biotechnology Market is set to garner staggering revenues by 2017 – 2025 – Hitz...

International Biotechnology Market Research The new document printed by TMRR at the world Biotechnology marketplace is an in-intensity research of the entire potentialities of the Biotechnology marketplace within the upcoming years. The knowledge...